Loxo Oncology's team of full-time professionals and engaged scientific advisors are aligned in choosing the most actionable targets and pursuing them through disciplined clinical trial approaches. The company's pipeline of products includes Larotrectinib, Loxo, etc. Loxo@Lilly, a global organization with team members in various locations, was created to bring together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, with the goal of generating a clinical path that reflects the underlying scientific hypothesis that made the drug interesting in the first place.